Skip to main content

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Media Contact: Amy Hytowitz, 949-250-5070

Investor Contact: Mark Wilterding, 949-250-6826

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.37
-5.74 (-2.73%)
AAPL  267.37
+2.79 (1.05%)
AMD  195.21
-4.94 (-2.47%)
BAC  51.27
-1.79 (-3.36%)
GOOG  312.81
-2.09 (-0.66%)
META  639.05
-16.61 (-2.53%)
MSFT  386.22
-11.01 (-2.77%)
NVDA  190.74
+0.92 (0.48%)
ORCL  139.68
-8.40 (-5.67%)
TSLA  394.62
-17.20 (-4.18%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.